Massive heart surgery trial aims to slash infection rates
NCT ID NCT06567808
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a second antibiotic (vancomycin) to the standard one (cefazolin) or giving antibiotics for a longer time can prevent serious infections after open-heart surgery. About 38,000 adults having heart surgery will be randomly assigned to one of four antibiotic plans. The goal is to find the safest and most effective way to stop surgical site infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTION, SURGICAL SITE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.